Director at VolitionRx (VNRX) granted 178,000 RSUs in lieu of cash
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Innes Guy Archibald reported acquisition or exercise transactions in this Form 4 filing.
VolitionRx Ltd director Guy Archibald Innes reported an equity compensation grant. On February 26, 2026 he was awarded 178,000 restricted stock units of common stock under the 2024 Stock Incentive Plan, in lieu of cash compensation.
The RSUs are earned in twelve approximately equal monthly installments starting February 1, 2026 and then vest in a single installment on February 26, 2027, subject to his continued service. Following this award, he directly owns 1,252,967 common shares, and also reports indirect holdings through a family trust, a charitable trust and family members.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Innes Guy Archibald
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 178,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,252,967 shares (Direct);
Common Stock — 1,400,000 shares (Indirect, By The Innes Family Bare Trust 2023)
Footnotes (1)
- On February 26, 2026, the reporting person was awarded 178,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date. These shares of Common Stock are beneficially owned by The Innes Family Bare Trust 2023, which is a separate legal entity, of which the reporting person is the Trustee, for the benefit of his children. These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. The reporting person serves as a director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
FAQ
What equity award did VolitionRx (VNRX) director Guy Archibald Innes receive?
Guy Archibald Innes received 178,000 restricted stock units (RSUs). The award was granted on February 26, 2026 as common stock RSUs under VolitionRx’s 2024 Stock Incentive Plan, issued in lieu of cash compensation that otherwise would have been owed to him.
How do the new RSUs for VolitionRx (VNRX) director Innes vest and earn?
The 178,000 RSUs are earned monthly and vest later. They are earned in twelve approximately equal monthly installments beginning February 1, 2026, then subject to additional time-based vesting in a single installment on February 26, 2027, contingent on his continued service throughout those periods.
Did VolitionRx (VNRX) director Innes pay cash for the 178,000 RSUs?
No cash payment was made for these RSUs. The award price per share is reported as $0.0000 because the RSUs were granted as equity compensation under the 2024 Stock Incentive Plan, in lieu of cash compensation that would otherwise have been paid.
How will the VolitionRx (VNRX) RSUs reported for Innes settle at vesting?
The RSUs will settle in VolitionRx common stock. Upon vesting and settlement, Innes will receive a number of common shares equal to the RSUs that have been earned and vested as of the February 26, 2027 vesting date.